As the U.S. markets hit record highs, driven by a surge in technology stocks, investors are increasingly turning their attention to growth companies with substantial insider ownership. In such a buoyant market environment, stocks with high insider ownership can be appealing as they often indicate strong confidence from those who know the company best.
Top 10 Growth Companies With High Insider Ownership In The United States
| Name | Insider Ownership | Earnings Growth |
| Upstart Holdings (UPST) | 12.6% | 93.2% |
| Niu Technologies (NIU) | 37.2% | 92.8% |
| IREN (IREN) | 11.2% | 59.3% |
| Hippo Holdings (HIPO) | 14.1% | 41.2% |
| Hesai Group (HSAI) | 15.7% | 41.5% |
| FTC Solar (FTCI) | 23.1% | 63% |
| Credo Technology Group Holding (CRDO) | 11.4% | 33% |
| Cloudflare (NET) | 10.5% | 46.1% |
| Atour Lifestyle Holdings (ATAT) | 21.8% | 23.5% |
| Astera Labs (ALAB) | 12.1% | 36.8% |
Let's explore several standout options from the results in the screener.
PDF Solutions (PDFS)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: PDF Solutions, Inc. offers proprietary software, intellectual property for integrated circuit designs, measurement hardware tools, methodologies, and professional services globally with a market cap of $792.23 million.
Operations: The company's revenue primarily comes from its Software & Programming segment, totaling $196 million.
Insider Ownership: 17.3%
PDF Solutions demonstrates strong growth potential with earnings forecasted to grow significantly, outpacing the US market. Despite a recent net loss for the first half of 2025, revenue increased to US$99.51 million from US$82.97 million year-over-year. The company reaffirmed its guidance for 21% to 23% annual revenue growth in 2025. Trading below fair value estimates and lacking recent insider trading activity, it remains an attractive option amidst high insider ownership dynamics.
- Get an in-depth perspective on PDF Solutions' performance by reading our analyst estimates report here.
- Our valuation report here indicates PDF Solutions may be undervalued.
Elastic (ESTC)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Elastic N.V. is a search artificial intelligence company that offers software platforms for hybrid, public or private clouds, and multi-cloud environments globally, with a market cap of approximately $9.26 billion.
Operations: The company's revenue primarily comes from its Software & Programming segment, generating $1.55 billion.
Insider Ownership: 12.1%
Elastic is poised for growth with anticipated profitability in three years and earnings projected to increase by 49.94% annually. Its revenue, expected to grow at 11.6% per year, surpasses the US market average but remains below 20%. Despite recent significant insider selling, analysts predict a stock price increase of 35.8%, with shares trading at 35.3% below fair value estimates. Recent product developments enhance Elastic's capabilities in observability and security analytics, potentially driving future performance improvements.
- Navigate through the intricacies of Elastic with our comprehensive analyst estimates report here.
- The valuation report we've compiled suggests that Elastic's current price could be quite moderate.
Hims & Hers Health (HIMS)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Hims & Hers Health, Inc. operates a telehealth platform connecting consumers with licensed healthcare professionals across the United States, the United Kingdom, and internationally, with a market cap of $11.38 billion.
Operations: The company's revenue segment includes $2.01 billion from online retailers.
Insider Ownership: 12.6%
Hims & Hers Health demonstrates potential for growth, with earnings showing a very large increase over the past year and revenue projected to grow faster than the US market. However, recent regulatory challenges include an FDA warning regarding misbranded compounded drugs and a terminated partnership with Novo Nordisk due to safety concerns, impacting investor confidence. Despite these hurdles, Hims & Hers continues expanding its product offerings in men's health while maintaining insider ownership stability without substantial recent insider buying or selling.
- Delve into the full analysis future growth report here for a deeper understanding of Hims & Hers Health.
- Insights from our recent valuation report point to the potential overvaluation of Hims & Hers Health shares in the market.
Make It Happen
- Access the full spectrum of 198 Fast Growing US Companies With High Insider Ownership by clicking on this link.
- Contemplating Other Strategies? Uncover the next big thing with financially sound penny stocks that balance risk and reward.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Valuation is complex, but we're here to simplify it.
Discover if Hims & Hers Health might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com